Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited
17. September 2017 18:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been...